Your browser doesn't support javascript.
loading
Design, synthesis and biological activity of N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amines as dual inhibitors of aurora kinase A and epidermal growth factor receptor kinase.
Kurup, Sonali; McAllister, Bradley; Liskova, Pavlina; Mistry, Trusha; Fanizza, Anthony; Stanford, Dan; Slawska, Jolanta; Keller, Ulrich; Hoellein, Alexander.
Afiliación
  • Kurup S; a College of Pharmacy , Roosevelt University , Schaumburg , IL , USA.
  • McAllister B; a College of Pharmacy , Roosevelt University , Schaumburg , IL , USA.
  • Liskova P; a College of Pharmacy , Roosevelt University , Schaumburg , IL , USA.
  • Mistry T; a College of Pharmacy , Roosevelt University , Schaumburg , IL , USA.
  • Fanizza A; b Department of Chemistry , Harper College , Palatine , IL , USA.
  • Stanford D; b Department of Chemistry , Harper College , Palatine , IL , USA.
  • Slawska J; c III. Medical Department , Technische Universität München , Munich , Germany.
  • Keller U; c III. Medical Department , Technische Universität München , Munich , Germany.
  • Hoellein A; d German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) , Heidelberg , Germany.
J Enzyme Inhib Med Chem ; 33(1): 74-84, 2018 Dec.
Article en En | MEDLINE | ID: mdl-29115879
Simultaneous inhibition of multiple kinases has been suggested to provide synergistic effects on inhibition of tumour growth and resistance. This study describes the design, synthesis and evaluation of 18 compounds incorporating a pyrrolo[2,3-d]pyrimidine scaffold for dual inhibition of epidermal growth factor receptor kinase (EGFR) and aurora kinase A (AURKA). Compounds 1-18 of this study demonstrate nanomolar inhibition of EGFR and micromolar inhibition of AURKA. Compounds 1-18 allow for a structure-activity relationships (SAR) analysis of the 4-anilino moiety for dual EGFR and AURKA inhibition. Compound 6, a 4-methoxyphenylpyrrolo[2,3-d]pyrimidin-4-amine, demonstrates single-digit micromolar inhibition of both AURKA and EGFR and provides evidence of a single molecule with dual activity against EGFR and AURKA. Compound 2, the most potent inhibitor of EGFR and AURKA from this series, has been further evaluated in four different squamous cell head and neck cancer cell lines for downstream effects resulting from AURKA and EGFR inhibition.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirimidinas / Pirroles / Diseño de Fármacos / Modelos Moleculares / Inhibidores de Proteínas Quinasas / Aurora Quinasa A / Receptores ErbB Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Enzyme Inhib Med Chem Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirimidinas / Pirroles / Diseño de Fármacos / Modelos Moleculares / Inhibidores de Proteínas Quinasas / Aurora Quinasa A / Receptores ErbB Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Enzyme Inhib Med Chem Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido